Global Gene Engineered Subunit Vaccine market cagr 11.9%

Page 1


Gene Engineered Subunit Vaccine Market

Gene Engineered Subunit Vaccine Market Scope:

Industry Analysis, Market Size, Growth, Trends Till 2031

Request Sample Report

Gene Engineered Subunit Vaccine Market Size and Growth

The Gene Engineered Subunit Vaccine market is rapidly expanding, driven by increased demand for innovative vaccine solutions. Current market size is estimated at approximately $5 billion, with growth projections highlighting advancements in genetic technology and rising infectious disease threats. Key competitive factors include efficacy, safety, and regulatory approvals.

Companies Covered

(Covid 19 Impact Covered)

◍ Merck

◍ GSK

◍ Tiantan

◍ Pulike

◍ Greffex

◍ CureVac

◍ Yebio

◍ Sanofi Pasteur SA

◍ Virbac

◍ Pfizer Inc.

◍ Walvax Biotechnology

◍ Kontec

The gene-engineered subunit vaccine market features key players like Merck, GSK, and Pfizer, focusing on innovative vaccine development. Companies leverage genetic engineering to enhance efficacy and safety, driving market growth. Revenue figures include Merck: $48 billion, GSK: $43.5 billion, and Pfizer: $81 billion, highlighting substantial market presence.

Request Sample Report

Market Segmentation

By Application

Human Use

Veterinary Use

By Product

◍ Therapeutic Gene Engineered Subunit Vaccine

Preventative Gene Engineered Subunit Vaccine

Request Sample Report

Market Growth

Request Sample Report

$ X Billion USD

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.